Nomura Next Funds Topix-17 Pharmaceutical 

¥32,570
0
+¥270+0.84%Monday 06:25

Statistics

Day High
32,900
Day Low
32,380
52W High
34,250
52W Low
26,285
Volume
1,095
Avg. Volume
1,142
Mkt Cap
0
P/E Ratio
-
Dividend Yield
2.14%
Dividend
697

Upcoming

Dividends

2.14%Dividend Yield
Aug 2026
¥697
Aug 2025
¥535
Aug 2024
¥646
Aug 2023
¥392
Aug 2022
¥357
10Y Growth
5.87%
5Y Growth
10.71%
3Y Growth
21.15%
1Y Growth
30.28%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1621.TSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Holdings

About

NA
Show More
CEO
Country
Japan
ISIN
JP3046600007

Listings

0 Comments

Share your thoughts

FAQs

What is Nomura Next Funds Topix-17 Pharmaceutical stock price today?▼
The current price of 1621.TSE is ¥32,570 JPY — it has increased by +0.84% in the past 24 hours. Watch Nomura Next Funds Topix-17 Pharmaceutical stock price performance more closely on the chart.
What is Nomura Next Funds Topix-17 Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange Nomura Next Funds Topix-17 Pharmaceutical stocks are traded under the ticker 1621.TSE.
Is Nomura Next Funds Topix-17 Pharmaceutical stock price growing?▼
1621.TSE stock has risen by +2.1% compared to the previous week, the month change is a +10.48% rise, over the last year Nomura Next Funds Topix-17 Pharmaceutical has showed a +21.85% increase.
Does Nomura Next Funds Topix-17 Pharmaceutical pay dividends?▼
Yes, 1621.TSE dividends are paid annual. The last dividend per share was 697 . As of today, Dividend Yield (FWD)% is 2.14%.
In which sector is Nomura Next Funds Topix-17 Pharmaceutical located?▼
Nomura Next Funds Topix-17 Pharmaceutical operates in the Other sector.
When did Nomura Next Funds Topix-17 Pharmaceutical complete a stock split?▼
Nomura Next Funds Topix-17 Pharmaceutical has not had any recent stock splits.